Shattuck Labs logo
Healthcare & Life Sciences

Shattuck Labs

Shattuck Labs is a series b startup based in United States. 2 investors tracked.

Activeseries-c-plus
series-c-plus
Stage
1
Investors

About Shattuck Labs

Shattuck Labs is a company headquartered in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

Shattuck Labs develops monoclonal antibody therapies targeting the DR3 receptor to treat Inflammatory Bowel Disease and other immune-mediated inflammatory conditions.

Explore Shattuck Labs's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in United States